Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
thrombosis 1 angiologydiseases
vascular disease 7 angiologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
thrombosis 19933 endothelial cells, vascular smooth muscle cells (VSMCs), and monocytes, and enhance vasoconstriction, thrombosis , and platelet aggregation. Furthermore, in atherosclerotic vessels, increased LDL levels stimulate endothelial
vascular disease 2290 Accumulating evidence indicates that LDL-containing immune complexes can also serve as biomarker for macro vascular disease in type 1 diabetes.1. IntroductionAtherosclerosis results in the inner layer of the arterial wall and
vascular disease 3202 obtained data about a relation of apolipoproteins to risk scores led to slight improvement in cardio vascular disease risk prediction [[10]].It is well known that atherosclerosis develops asymptomatically affecting the
vascular disease 4130 immune complexes which emerge to be diagnostic and prognostic biomarker of atherosclerosis and macro vascular disease in type 1 diabetes.2. Low Density LipoproteinLipid deposition in the arterial wall is widely recognized
vascular disease 14023 trimethylamine N-oxide (TMAO), and betaine, e.g., to catabolites that increase risk of atherosclerosis and cardio vascular disease [[55]].Sphingomyelin is an essential structural component of serum lipoproteins and the second major
vascular disease 18757 apoB and apoA-I, lipoprotein (a), or lipoprotein-associated phospholipase A2 does not improve cardio vascular disease (CVD) prediction but adding these markers to the combination of total cholesterol and HDL cholesterol
vascular disease 25792 by a specific monoclonal antibody for atherosclerosis-related events including coronary and cerebral vascular disease . In a follow-up study of 326 clinically healthy Swedish men, Wallenfeldt et al. [[105]] showed association
vascular disease 61081 complexes may provide a physiological link and explain whereby elevated LDL levels contribute to macro vascular disease in type 1 diabetes. Similar experiments should be performed in atherosclerotic patients and type 2 diabetic

You must be authorized to submit a review.